Rural Health
News by Topic: Pharmacy and prescription drugs

DEA: Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients Federal Register

Mar 24, 2025 - Notice of final rule from the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) further delaying the January 17, 2025, final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules will now be effective December 31, 2025.

view details

DEA: Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients Federal Register

Feb 19, 2025 - Notice from the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) delaying the January 17, 2025, final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients" in accordance with the January 20, 2025, presidential memorandum titled "Regulatory Freeze Pending Review." These final rules will now be effective March 21, 2025. Comments regarding the delayed effective date are due by February 28, 2025.

view details

HHS: Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard; Delay of Effective Date Federal Register

Feb 11, 2025 - Notice from the U.S. Department of Health and Human Services (HHS) delaying the effective date of the December 13, 2024, final rule in accordance with the January 20, 2025, presidential memorandum titled "Regulatory Freeze Pending Review." The final rule is now effective April 14, 2025, and the compliance date is also delayed until April 14, 2028.

view details